| Secondary |
| Diabetes Mellitus Non-insulin-dependent |
30.5% |
| Type 2 Diabetes Mellitus |
20.7% |
| Diabetes Mellitus |
14.6% |
| Completed Suicide |
12.2% |
| Drug Use For Unknown Indication |
3.7% |
| Type Ii Diabetes Mellitus |
3.7% |
| Balance Disorder |
2.4% |
| Weight Control |
2.4% |
| Hypertension |
1.2% |
| Irritable Bowel Syndrome |
1.2% |
| Migraine |
1.2% |
| Muscle Spasms |
1.2% |
| Oedema |
1.2% |
| Sedative Therapy |
1.2% |
| Thrombosis Prophylaxis |
1.2% |
| Varicose Vein Ruptured |
1.2% |
|
| Weight Decreased |
25.6% |
| Weight Increased |
12.8% |
| Tooth Disorder |
7.7% |
| Dyspnoea Exertional |
5.1% |
| Syncope |
5.1% |
| Weight Loss Poor |
5.1% |
| Wheezing |
5.1% |
| Arthralgia |
2.6% |
| Cardio-respiratory Arrest |
2.6% |
| Cataract |
2.6% |
| Completed Suicide |
2.6% |
| Diabetes Mellitus |
2.6% |
| Dizziness |
2.6% |
| Intentional Drug Misuse |
2.6% |
| Liver Disorder |
2.6% |
| Myocardial Infarction |
2.6% |
| Personality Change |
2.6% |
| Pneumonia |
2.6% |
| Purpura |
2.6% |
| Renal Failure |
2.6% |
|
| Concomitant |
| Type 2 Diabetes Mellitus |
46.2% |
| Drug Use For Unknown Indication |
15.8% |
| Diabetes Mellitus |
12.6% |
| Hypertension |
5.4% |
| Insulin-requiring Type 2 Diabetes Mellitus |
3.0% |
| Smoking Cessation Therapy |
2.1% |
| Depression |
2.0% |
| Product Used For Unknown Indication |
2.0% |
| Pain |
1.7% |
| Diabetes Mellitus Non-insulin-dependent |
1.3% |
| Blood Cholesterol Increased |
1.1% |
| Schizoaffective Disorder |
1.0% |
| Type 1 Diabetes Mellitus |
0.9% |
| Peritoneal Dialysis |
0.9% |
| Diabetic Neuropathy |
0.8% |
| Metabolic Syndrome |
0.8% |
| Osteoporosis |
0.8% |
| Insomnia |
0.6% |
| Back Pain |
0.5% |
| Blood Pressure Increased |
0.5% |
|
| Weight Decreased |
23.9% |
| Blood Glucose Increased |
16.1% |
| Nausea |
13.2% |
| Vomiting |
7.5% |
| Weight Increased |
6.7% |
| Drug Ineffective |
4.7% |
| Tremor |
3.7% |
| Drug Effect Decreased |
3.5% |
| Incorrect Dose Administered |
3.5% |
| Somnolence |
2.3% |
| Pain |
1.9% |
| Glycosylated Haemoglobin Increased |
1.8% |
| Injection Site Haemorrhage |
1.8% |
| Malaise |
1.6% |
| Vision Blurred |
1.6% |
| Hypoglycaemia |
1.4% |
| Hyperglycaemia |
1.2% |
| Injection Site Pain |
1.2% |
| Nasopharyngitis |
1.2% |
| Oedema Peripheral |
1.2% |
|
| Interacting |
| Diabetes Mellitus |
25.0% |
| Blood Cholesterol Increased |
16.7% |
| Blood Glucose Increased |
16.7% |
| Herpes Zoster |
16.7% |
| Post Herpetic Neuralgia |
16.7% |
| Erectile Dysfunction |
8.3% |
|
| Sleep Disorder |
66.7% |
| Hearing Impaired |
33.3% |
|
